← Insider buys
REPH

Recro Pharma, Inc.

Possible Member of 10% Group, 10% James E Flynn sold $444K of Recro Pharma, Inc.

Sold$444,010
$7.06Price
62,868Shares
−3%Stake

What REPH did after the filing

Prices for REPH after this filing aren't in yet.

Traded Wed, Jun 7. Filed Fri, Jun 9, 4:07 PM ET, after the close. Not investment advice.